enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
10.40
+0.05 (0.48%)
At close: Feb 26, 2026, 4:00 PM EST
10.40
0.00 (0.00%)
After-hours: Feb 26, 2026, 4:00 PM EST
enVVeno Medical Employees
enVVeno Medical had 37 employees as of December 31, 2024. The number of employees increased by 6 or 19.35% compared to the previous year.
Employees
37
Change (1Y)
6
Growth (1Y)
19.35%
Revenue / Employee
n/a
Profits / Employee
-$593,649
Market Cap
6.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 37 | 6 | 19.35% |
| Dec 31, 2023 | 31 | 1 | 3.33% |
| Dec 31, 2022 | 30 | 6 | 25.00% |
| Dec 31, 2021 | 24 | 5 | 26.32% |
| Dec 31, 2020 | 19 | 7 | 58.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Lifeward | 80 |
| Beyond Air | 61 |
| Intelligent Bio Solutions | 55 |
| Biomerica | 54 |
| PAVmed | 39 |
| Movano | 32 |
| Tenon Medical | 27 |
| HeartSciences | 15 |
NVNO News
- 22 days ago - enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Accesswire
- 6 weeks ago - enVVeno Medical Announces Reverse Stock Split - Accesswire
- 3 months ago - enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - Accesswire
- 3 months ago - enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - Accesswire
- 4 months ago - enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Accesswire
- 5 months ago - enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment - Accesswire
- 5 months ago - enVVeno Medical Updates Regulatory Status of VenoValve(R) - Accesswire
- 6 months ago - enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R) - Accesswire